Following the UW CFAR award in 1988, the UW Center for AIDs and STD (CAS) was formed to coordinate all academic activities for both AIDS & STD at the six UW Health Services Schools and affiliated institutions. This has let to efficient and complementary organization of clinical, training, and research activities. The UW CAS administers two NIAID Research Centers, the CFAR and the STD CRC; directs medical care for three ambulatory clinics currently serving over 1,000 patients with HIV infection, two STD/HIV clinics, serving over 20,000 patients visits per year, and several HIV/STD research clinics. Six regional and international HIV/STD training programs are directly administered or coordinated by the CAS, including 3 clinical and 3 research training programs. The CAS is also funded by USAID/Family Health International to provide assistance and conduct operational research on AIDS prevention in developing countries. At present, 90 CFAR affiliated faculty are involved in AIDS/HIV-related research. Total federal funding for CFAR- affiliated investigators total $19,000,000 for AIDS/HIV-related research, including over $9,700,000 from NIAID; and over $6,700,000 for other STD- related research. Key NIAID HIV research grants in addition to the CFAR, include the following: ACTU; Pediatric-Perinatal ACTU; AVEU; NCDVG; PAVE; PEBRA; two AIDS Research Training Grants and several R01 grants. The CFAR coordinated development of 5,800 square feet of CFAR laboratory space for AIDS research (and will develop another 3,800 sq ft); and approximately 33,500 sq ft. of renovated space for CAS-related clinics, training, and research programs, including the clinical research, biostatistical, epidemiologic and administration cores for the CFAR and the STD CRC. The CFAR and its Internal and External Review Committees have made six New Transmission and Early Infection; Epidemiology, Pathogenesis, and Prevention. This theme describes and focuses much of the AIDS work in progress at the University of Washington and its affiliated institutions, including work in animal models, clinical epidemiologic studies of sexual and perinatal transmission in developing countries, clinical studies of genital shedding of HIV, the current CFAR has been reorganized into Administration and Developmental Cores (funding up to 10 New Investigators and new program development), and the following scientific cores, oriented around the theme of the CFAR. Clinical Research (including an International Clinical Research component); Clinical Retrovirology; Molecular Retrovirology; Immunology; Biostatistics; and AIDS Registry. A Large Scale DNA Sequencing core is planed for the 07 year.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-09
Application #
2376329
Study Section
Special Emphasis Panel (SRC (71))
Project Start
1988-09-30
Project End
1999-02-28
Budget Start
1997-03-01
Budget End
1998-02-28
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Fredericksen, Rob J; Mayer, Kenneth H; Gibbons, Laura E et al. (2018) Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care. J Gen Intern Med 33:1661-1668
Wilson, Kate S; Wanje, George; Masese, Linnet et al. (2018) A Prospective Cohort Study of Fertility Desire, Unprotected Sex, and Detectable Viral Load in HIV-Positive Female Sex Workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 78:276-282
Ikoma, Minako; Gantt, Soren; Casper, Corey et al. (2018) KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite. PLoS One 13:e0192659
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Gómez, Laurén A; Crowell, Claudia S; Njuguna, Irene et al. (2018) Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children. Pediatr Infect Dis J 37:916-922
Thomson, Kerry A; Dhanireddy, Shireesha; Andrasik, Michele et al. (2018) Fertility desires and preferences for safer conception strategies among people receiving care for HIV at a publicly-funded clinic in Seattle, WA. AIDS Care 30:121-129
Lohman-Payne, Barbara; Gabriel, Benjamin; Park, Sangshin et al. (2018) HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort. Clin Transl Med 7:26
McGrath, Christine J; Singa, Benson; Langat, Agnes et al. (2018) Non-disclosure to male partners and incomplete PMTCT regimens associated with higher risk of mother-to-child HIV transmission: a national survey in Kenya. AIDS Care 30:765-773
Njuguna, Irene N; Wagner, Anjuli D; Omondi, Vincent O et al. (2018) Financial Incentives for Pediatric HIV Testing in Kenya. Pediatr Infect Dis J 37:1142-1144

Showing the most recent 10 out of 1275 publications